Multiple endocrine neoplasia, type 2
Also known as:
Multiple endocrine neoplasia type 2 (MEN 2) is a genetic disorder associated with a high lifetime risk of medullary thyroid cancer (MTC). It is caused by germlinemutations in the RET proto-oncogene.
Patients and families benefit from some of the finest, most comprehensive cancer services in the world, including the best in diagnostic imaging, state-of-the-art treatments, nationally-renowned research, and compassionate counseling and support. Our doctors, surgeons, nurses, researchers, patient advocates and other caregivers work together to treat cancer aggressively and to ensure that no person has to face the challenge of a cancer diagnosis alone.